Variable | Vildagliptin group (n = 25) | Control group (n = 25) | p value |
---|---|---|---|
Age (years) | |||
 Mean ± SD | 16.5 ± 3.5 | 17.1 ± 4.2 | 0.586 |
Gender, n (%) | |||
 Male | 13 (52) | 11 (44) | 0.571 |
 Female | 12 (48) | 14 (56) | |
Weight SDS | |||
 Median (IQR) | 0.25 (0.08–1.43) | 0.31 (0.18–1.23) | 0.892 |
BMI SDS | |||
 Median (IQR) | 1.21 (0.10–1.76) | 1.17 (0.4–1.6) | 0.899 |
Diabetes duration (years) | |||
 Mean ± SD | 7.52 ± 2.65 | 7.12 ± 2.45 | 0.582 |
AHCL therapy duration (years) | |||
 Mean ± SD | 1.93 ± 0.86 | 1.72 ± 0.75 | 0.362 |